Somewhat Positive Press Coverage Very Unlikely to Impact AstraZeneca (LON:AZN) Stock Price

Share on StockTwits

Media headlines about AstraZeneca (LON:AZN) have been trending somewhat positive on Sunday, according to InfoTrie. The research firm scores the sentiment of media coverage by analyzing more than 6,000 blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. AstraZeneca earned a coverage optimism score of 1.52 on their scale. InfoTrie also assigned news coverage about the biopharmaceutical company an news buzz score of 2 out of 10, indicating that recent media coverage is very unlikely to have an effect on the company’s share price in the near term.

Here are some of the headlines that may have effected AstraZeneca’s analysis:

LON:AZN opened at GBX 8,996 ($118.34) on Friday. The stock has a market cap of $118.06 billion and a P/E ratio of 77.75. AstraZeneca has a one year low of GBX 5,739 ($75.49) and a one year high of GBX 9,335 ($122.80). The company has a fifty day moving average price of GBX 8,037.56 and a 200 day moving average price of GBX 7,545.94. The company has a debt-to-equity ratio of 171.72, a current ratio of 0.75 and a quick ratio of 0.56.

A number of analysts have issued reports on AZN shares. DZ Bank lifted their target price on shares of AstraZeneca from GBX 6,500 ($85.50) to GBX 7,300 ($96.03) and gave the company a “sell” rating in a research note on Friday, May 1st. Goldman Sachs Group set a GBX 6,000 ($78.93) target price on shares of AstraZeneca and gave the company a “sell” rating in a research note on Friday, May 15th. HSBC lifted their target price on shares of AstraZeneca from GBX 6,450 ($84.85) to GBX 6,690 ($88.00) and gave the company a “reduce” rating in a research note on Thursday, April 30th. Bryan, Garnier & Co lifted their target price on shares of AstraZeneca from GBX 8,550 ($112.47) to GBX 8,780 ($115.50) and gave the company a “buy” rating in a research note on Monday, May 11th. Finally, Credit Suisse Group lifted their target price on shares of AstraZeneca from GBX 8,500 ($111.81) to GBX 9,000 ($118.39) and gave the company an “outperform” rating in a research note on Thursday, April 30th. Four research analysts have rated the stock with a sell rating, two have assigned a hold rating and fourteen have given a buy rating to the stock. AstraZeneca presently has a consensus rating of “Buy” and a consensus price target of GBX 8,168.89 ($107.46).

AstraZeneca Company Profile

AstraZeneca PLC discovers, develops, and commercializes prescription medicines in the areas of oncology, cardiovascular, renal and metabolism, respiratory, autoimmunity, infection, neuroscience, and gastroenterology worldwide. Its marketed products include Arimidex, Casodex/Cosudex, Calquence, Faslodex, Imfinzi, Iressa, Lynparza, Nolvadex, Tagrisso, and Zoladex for oncology diseases; Atacand1/Atacand HCT/Atacand Plus, Brilinta/Brilique, Crestor, Plendil, Seloken/Toprol-XL, Tenormin, and Zestril for cardiovascular diseases; and Bydureon, Byetta, Farxiga/Forxiga, Kombiglyze XR, Komboglyze, Onglyza, Qtern, Symlin, Xigduo, and Xigduo XR for metabolic diseases.

See Also: What causes a recession?

Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Northwestern Mutual Investment Management Company LLC Acquires 2,288 Shares of Campbell Soup
Northwestern Mutual Investment Management Company LLC Acquires 2,288 Shares of Campbell Soup
Russell Investments Group Ltd. Sells 6,143 Shares of AlarmCom Hldg Inc
Russell Investments Group Ltd. Sells 6,143 Shares of AlarmCom Hldg Inc
Northwestern Mutual Investment Management Company LLC Has $414,000 Position in Universal Health Services, Inc.
Northwestern Mutual Investment Management Company LLC Has $414,000 Position in Universal Health Services, Inc.
Northwestern Mutual Wealth Management Co. Sells 672 Shares of Gartner Inc
Northwestern Mutual Wealth Management Co. Sells 672 Shares of Gartner Inc
NRG Energy Inc  Shares Bought by Commerce Bank
NRG Energy Inc Shares Bought by Commerce Bank
Sunrun Inc  Shares Bought by Rhumbline Advisers
Sunrun Inc Shares Bought by Rhumbline Advisers


© 2006-2020 Ticker Report